-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
Microbiome and metabolomic analyses of previous studies of NCDs have paid little attention to major confounders of findings, such as common, pre-onset and comorbid conditions or polypharmacy
Epidemiological and genetic studies in humans and experimental studies in animals suggest that the pathogenesis of the most common chronic noncommunicable diseases involves complex interactions between polygenic susceptibility, aging, gender and multiple environmental exposures1
Current microbiome and metabolome research has focused on IHD, which is the leading cause of death worldwide
In the MetaCardis Consortium, we designed the current cross-sectional study, including healthy individuals, patients with metabolic abnormalities, and patients with IHD at three different clinical stages, to obtain the broad gut microbiota, plasma and urine metabolism of cardiometabolic diseases (CMDs) group characteristics
Microbiome and metabolome features of the cardiometabolic disease spectrum